![]() |
|
|
Vol. 302, Issue 1, 174-179, July 2002
Pharmacology Section, Instituto de Investigaciones Clinicas, School
of Medicine, University of Zulia, Maracaibo, Venezuela (H.S.-R.);
Clinical Pharmacology and Neuropharmacology Units, Department of
Pharmacology, School of Pharmacy, Central University of Venezuela,
Caracas, Venezuela (L.X.C.); and Nova Southeastern University, Health
Professions Division, Fort Lauderdale, Florida (L.X.C.)
We investigated whether selective inhibition of serotonin
(5-hydroxytryptamine; 5-HT) transporter with citalopram leads to accumulation of 5-HT in catecholaminergic neurons. In the rabbit olfactory tubercle, citalopram (1-10 µM) inhibited
[3H]5-HT uptake; however, the maximal degree of
inhibition achieved was 70%. Addition of nomifensine (1-10 µM) was
required for complete inhibition of [3H]5-HT uptake. In
slices labeled with 0.1 µM [3H]5-HT, cold 5-HT (0.03-1
µM) induced a large increase in the efflux (release) of stored
[3H]5-HT, an effect blocked by coperfusion with 1 µM
citalopram. Similar concentrations (0.03-1 µM) of norepinephrine
(NE) or dopamine (DA) failed to release [3H]5-HT. When
labeling with 0.1 µM [3H]5-HT was carried out in the
presence of citalopram, 1) low concentrations of 5-HT failed to release
[3H]5-HT; 2) DA and NE were more potent and effective in
releasing [3H]5-HT than in control slices; 3) coperfusion
of NE, DA, or 5-HT with citalopram enhanced the release of
[3H]5-HT induced by the catecholamines but not by 5-HT;
and 4) coperfusion of NE or DA with nomifensine antagonized NE- and
DA-evoked [3H]5-HT release, with a greater effect on NE
than on DA. These results suggest that in the rabbit olfactory
tubercle, where there is coexistence of 5-HT, NE, and DA neurons,
inhibition of the 5-HT transporter led to accumulation of 5-HT in
catecholaminergic terminals. Thus, during treatment with selective
serotonin uptake inhibitors (SSRIs), 5-HT may be stored in
catecholaminergic neurons acting as a false neurotransmitter and/or
affecting the disposition of DA and/or NE. Transmitter relocation may
be involved in the antidepressant action of SSRIs.